People

Dr Moira Cruickshank

Dr Moira Cruickshank
Dr Moira Cruickshank
Dr Moira Cruickshank

Research Fellow

About
Email Address
m.cruickshank@abdn.ac.uk
Office Address

 

Health Services Research Unit
3rd Floor Health Sciences Building
Foresterhill
Aberdeen
AB25 2ZD

 

School/Department
School of Medicine, Medical Sciences and Nutrition

Biography

Moira Cruickshank is a Research Fellow in the Evidence Synthesis programme of ACE.

Moira was a Police Officer in the Metropolitan Police Service before returning to full time education at the University of Aberdeen in 2002, graduating with BSc (Hons) Psychology in 2006, MRes Psychology in 2007 and PhD Psychology in 2011. Since then, Moira has been a systematic reviewer within the Evidence Synthesis programme and is involved in technology assessment appraisals and health technology assessment reviews.

Publications

Page 2 of 6 Results 11 to 20 of 56

  • The effects and safety of testosterone replacement therapy for men with hypogonadism: The TestES evidence synthesis and economic evaluation

    Cruickshank, M., Hudson, J., Hernández, R., Aceves-Martins, M., Quinton, R., Gillies, K., Aucott, L. S., Kennedy, C., Manson, P., Oliver, N., Wu, F., Bhattacharya, S., Dhillo, W. S., Jayasena, C. N., Brazzelli, M.
    Health Technology Assessment, vol. 28, no. 43
    Contributions to Journals: Articles

  • Fruquintinib for previously treated metastatic colorectal cancer [ID6274]: NICE Single Technology Appraisal

    Boyers, D., Booth, C., Cruickshank, M., Kilonzo, M., Cooper, D., Manson, P., Braun, M., Brazzelli, M.
    Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA Group
    Books and Reports: Commissioned Reports

  • What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence

    Cruickshank, M., Brazzelli, M., Manson, P., Torrance, N., Grant, A.
    PloS ONE, vol. 19, no. 3 , e0299743
    Contributions to Journals: Review articles

  • Cost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels

    Hernández, R., de Silva, N. L., Hudson, J., Cruickshank, M., Quinton, R., Manson, P., Dhillo, W. S., Bhattacharya, S., Brazzelli, M., Jayasena, C. N.
    Andrology, vol. 12, no. 3, pp. 477-486
    Contributions to Journals: Articles

  • Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments

    Imamura, M., Getaneh, A., Cooper, D., Cruickshank, M., Manson, P., Shaukat, A. A., Brazzelli, M., Scotland, G.
    National Institute for Health and Care Excellence (NICE). 20 pages
    Books and Reports: Commissioned Reports

  • Netarsudil-latanoprost for previously treated openangle glaucoma or ocular hypertension [ID1363]: NICE Single Technology Appraisal

    Boyers, D., Scott, N., Cruickshank, M., Azharuddin, M., Hernández, R. A., Ayansina, D., Manson, P., Virgili, G., Azuara-Blanco, A., Brazzelli, M.
    Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA Group
    Books and Reports: Commissioned Reports

  • Clinical Predictors Of Symptomatic Benefit In Men With Low Testosterone During Testosterone Treatment Compared With Placebo:: Results Of Individual Patient And Aggregate Data Meta-analyses

    Hudson, J., Cruickshank, M., Quinton, R., Aucott, L., Wu, F. C. W., Grossmann, M., Bhasin, S., Snyder, P., Ellenberg, S., Travison, T., Brock, G., Gianatti, E. J., Van Der Schouw, Y. T., Ramachandran, S., Svartberg, J., Hildreth, K., Antonic, K. G., Tenover, J. S., Tan, H. M., Ho Chee Kong, C., Shen Tan, W., Marks, L. S., Ross, R. J. M., Schwartz, R., Roberts, S., Andersen, M., Magnussen, L., Aceves Martins, M., Bhattacharya, S., Dhillo, W. S., Brazzelli, M., Jayasena, C. N.
    Annual Meeting of the Endocrine Society 2023, bvad114.1704
    Contributions to Journals: Abstracts

  • Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis

    Hudson, J., Cruickshank, M., Quinton, R., Aucott, L., Wu, F., Grossmann, M., Bhasin, S., Snyder, P. J., Ellenberg, S. S., Travison, T. G., Brock, G. B., Gianatti, E. J., van der Schouw, Y. T., Emmelot-Vonk, M. H., Giltay, E. J., Hackett, G., Ramachandran, S., Svartberg, J., Hildreth, K. L., Antonic, K. G., Tenover, J. L., Tan, H. M., Ho Chee Kong, C., Tan, W. S., Marks, L. S., Ross, R. J., Schwartz, R. S., Manson, P., Roberts, S. A., Skovsager Andersen, M., Velling Magnussen, L., Aceves-Martins, M., Gillies, K., Hernández, R., Oliver, N., Dhillo, W. S., Bhattacharya, S., Brazzelli, M., Jayasena, C. N.
    The Lancet Healthy Longevity, vol. 4, no. 10, pp. e561-e572
    Contributions to Journals: Articles

  • Deucravacitinib for treating moderate-to-severe plaque psoriasis

    Cruickshank, M., Cooper, D., Crozier, A., Robertson, C., Aucott, L., Manson, P., Ormerod, A., Scotland, G., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 155 pages
    Books and Reports: Commissioned Reports

  • Secukinumab for Moderate-to-Severe Hidradenitis Suppurativa [ID4039]: NICE Single Technology Appraisal

    Scott, N., Kumar, S., Tsehaye, M., Imamura, M., Cruickshank, M., Manson, P., Ormerod, A., Brazzelli, M., Boyers, D.
    Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA Group
    Books and Reports: Commissioned Reports
Show 10 | 25 | 50 | 100 results per page

Refine

Books and Reports

Contributions to Conferences

Contributions to Journals

Update